Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas

Gut

Volumn 44, Issue 6, 1999, Pages 826-833

  Rashid, A ^a   Zahurak, M ^a   Goodman, S N ^a   Hamilton, S R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

K ras mutation; Loss of 18q; Microsatellite instability; p53 gene; Replication error; TGF RII

Indexed keywords

DNA; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 18Q; CHROMOSOME LOSS; COLON ADENOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DEMOGRAPHY; DNA REPLICATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC EPIDEMIOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR GENE; RECTUM ADENOMA; TUMOR SUPPRESSOR GENE;

EID: 0033021390     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.6.826     Document Type: Article

References (55)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
2. Reale MA, Fearon ER. Gene defects in colorectal tumorigenesis. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996:63-86.
3. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer (HNPCC): the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114-25.
4. Perucho M. Microsatellite instability: the mutator that mutates the other mutator. Nat Med 1996;2;630-1.
5. Miyaki M, Seki M, Okamoto M, et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990;50:7166-73.
6. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
7. Boland CR, Sato J, Appelman HD, et al. Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nat Med 1995;1:902-9.
8. De Benedetti L, Varesco L, Pellegata NS, et al. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression. Anticancer Res 1993;13:667-70.
9. Scott N, Bell SM, Sagar P, et al. p53 expression and K-ras mutation in colorectal adenomas. Gut 1993;34:621-4.
10. McLellan EA, Owen RA, Stepniewska KA, et al. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 1993;34:392-6.
11. Yamagata S, Muto T, Uchida Y, et al. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Jpn J Cancer Res 1994;85:147-51.
12. Ajiki T, Fujimori T, Ikehara H, et al. K-ras gene mutation related to histological atypias in human colorectal adenomas. Biotech Histochem 1995;70:90-4.
13. Giaretti W, Pujic N, Rapallo A, et al. K-ras-2 G-C and G-T transversions correlate with DNA ancuploidy in colorectal adenomas. Gastroenterology 1995;108:1040-7.
14. Morris RG, Curtis LJ, Romanowski P, et al. Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol 1996;180:357-63.
15. Nusko G, Sachse R, Mansmann U, et al. K-ras-2 gene mutations as predictors of metachronous colorectal adenomas. Scand J Gastroenterol 1997;32:1035-41.
16. Saraga E, Bautista D, Dorta G, et al. Genetic heterogeneity in sporadic colorectal adenomas. J Pathol 1997;181:281-6.
17. Kikuchi-Yanoshita R, Konishi M, Fakunari H, et al. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and nonfamilial adenomatous polyposis patients. Cancer Res 1992;52:3801-3.
18. Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumor suppressor genes on chromosomes 18 in colorectal cancers. Nat Genet 1996;13:343-6.
19. Riggins GJ, Thiagalingam S, Rozenblum E, et al. Mad-related genes in the human. Nat Genet 1996;13:347-9.
20. Darmon E, Cleary KR, Wargovich MJ. Immunohistochemical analysis of p53 overexpression in human colonic tumors. Cancer Detection Prevention 1994;18:187-95.
21. Kaklamanis L, Gatter KC, Mortensen N, et al. p53 expression in colorectal adenomas. Am J Pathol 1993;142:87-93.
22. Ohue M, Tomita N, Monden T, et al. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 1994;54:4798-804.
23. Yamaguchi A, Makimoto K, Goi T, et al. Overexpression of p53 protein and proliferative activity in colorectal adenoma. Oncology 1994;51:224-7.
24. Hasegawa H, Ueda M, Watanabe M, et al. K-ras gene mutations in early colorectal cancer. Flat elevated vs polypforming cancer. Oncogene 1995;10:1413-16.
25. Yamagata S, Muto T, Uchida Y, et al. Polypoid growth and K-ras codon 12 mutation in colorectal cancer. Cancer 1995;75:953-7.
26. Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
27. Akiyama Y, Iwanaga R, Saitoh K, et al. Transforming growth factor β type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 1997;112:33-9.
28. Young J, Leggett B, Gustafson C, et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 1993;2:351-4.
29. Aaltonen LA, Peltomaki P, Mecklin J-P, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
30. Jacoby RF, Marshall DJ, Kailas S, et al. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 1995;109:73-82.
31. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996;111:307-17.
32. Samowitz WS, Slattery ML. Microsatellite instability in colorectal adenomas. Gastroenterology 1997;112:1515-19.
33. Samowitz WS, Slattery ML. Transforming growth factor-β receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. Gastroenterology 1997;151:33-5.
34. Vasen HLA, Mecklin J-P, Merra Khan P, et al. The international collaborative group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
35. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and parraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-26.
36. Jen J, Powell SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994;54:5523-6.
37. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997;113:127-35.
38. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. New Engl J Med 1994;331:213-21.
39. Baas IO, Mulder J-WR, Offerhaus GJA, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
40. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
41. Kim H, Jen, J, Vogelstein B, et al. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
42. Hayashi N, Sugai S, Ito I, et al. Ethnic difference in the pattern of K-ras oncogene mutations in human colorectal cancers. Hum Mutat 1996;8:258-61.
43. Breivik J, Meling GI, Spurkland A, et al. K-ras mutation in colorectal cancer: relations to patient age, sex and tumor location. Br J Cancer 1994;69:367-71.
44. Shibata D, Schaeffer J, Li Z-H, et al. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Institute 1993;85:1058-63.
45. Moerkerk P, Arends JW, van Driel M, et al. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994;54:3376-8.
46. Benhattar J, Losi L, Chaubert P, et al. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 1993;104:1044-8.
47. Grady WM, Rajput A, Myeroff L, et al. Mutation of the type II transforming growth factor β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998;58:3101-4.
48. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:4749-56.
49. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
50. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-16.
51. Craanen ME, Blok P, Offerhaus GJ, et al. Recent developments in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol Suppl 1996;218:92-7.
52. Ruschoff J, Dietmaier W, Luttges J, et al. Poorly differentiated colonic adenocarcinomas, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol 1997;150:1815-25.
53. Tannergard P, Liu T, Weger A, et al. Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet 1997;101:51-5.
54. Olschwang S, Hamelin R, Laurent-Puig P, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 1997;94:12122-7.
55. Arends JW, Bosman FT. The conceptual and practical impact of Ki-ras mutation in colorectal neoplasia. J Pathol 1996;180:355-6.